Sequent and Viyash Life merger plan gets shareholder approval

September 4, 2025

The proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ₹8,000-crore merger aims to create a global entity, combining Sequent’s animal health focus with Viyash’s human health expertise. Hari Babu Bodepudi, the proposed group CEO, highlights opportunities in animal health generics and leveraging synergies between the companies’ manufacturing capabilities.

More To Explore

BofA Securities enters Kaynes Technologies via Rs 42 crore block deal; stock down 48% in six months

BofA Securities acquired 1.16 lakh Kaynes Technologies shares via a block deal, while the stock continues a multi-month downtrend despite rising revenue and quarterly profit

March 12, 2026

Innovision extends IPO till March 17 after failing to reach full subscription, lowers price band

Innovision’s IPO has been extended to March 17 after 32% subscription, reflecting weak investor interest; the price band was revised lower, while revenue growth is

March 12, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003